Efficacy of Control-IQ Technology in a General Endocrine Clinic

Usoh, Chinenye O.; Price, Catherine; Johnson, Crystal Paige; Speiser, Jaime L.; Aloi, Joseph

doi:10.1016/j.eprac.2022.10.010

Cited by 2 publications

(1 citation statement)

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The efficacy of Tandem Control-IQ in adults was demonstrated also by Usoh et al analyzing data from 66 patients who switched from multi-injection therapy to Tandem t:slim X2 from January 2020 to June 2021: it resulted in a significant increase in TIR (from 49.5% to 63.3%) and reduction in HbA1C levels (from 7.7% to 7.1%) [ 44 ].…”

Section: Use Of Ahcl By Age Groupmentioning

confidence: 94%

Automated Insulin Delivery (AID) Systems: Use and Efficacy in Children and Adults with Type 1 Diabetes and Other Forms of Diabetes in Europe in Early 2023

Bassi

Franzone

Dufour

et al. 2023

Life

View full text Add to dashboard Cite

Type 1 diabetes (T1D) patients’ lifestyle and prognosis has remarkably changed over the years, especially after the introduction of insulin pumps, in particular advanced hybrid closed loop systems (AHCL). Emerging data in literature continuously confirm the improvement of glycemic control thanks to the technological evolution taking place in this disease. As stated in previous literature, T1D patients are seen to be more satisfied thanks to the use of these devices that ameliorate not only their health but their daily life routine as well. Limited findings regarding the use of new devices in different age groups and types of patients is their major limit. This review aims to highlight the main characteristics of each Automated Insulin Delivery (AID) system available for patients affected by Type 1 Diabetes Mellitus. Our main goal was to particularly focus on these systems’ efficacy and use in different age groups and populations (i.e., children, pregnant women). Recent studies are emerging that demonstrate their efficacy and safety in younger patients and other forms of diabetes.

show abstract

Section: Use Of Ahcl By Age Groupmentioning

confidence: 94%